# Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World

> **NCT00703924** · PHASE2 · COMPLETED · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 92 (actual)

## Conditions studied

- Cutaneous Leishmaniasis

## Interventions

- **DRUG:** WR 279,396
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00703924
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2004-11
- **Final completion:** 2005-11
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2017-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00703924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00703924, "Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00703924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*